APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dental Anti-inflammatory Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dental Anti-inflammatory Drugs Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchDental Anti-inflammatory Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Dental Anti-inflammatory Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Dental Anti-inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dental Anti-inflammatory Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dental Anti-inflammatory Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dental Anti-inflammatory Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dental Anti-inflammatory Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dental Anti-inflammatory Drugs market include 3M, Yunnan Baiyao Group, Johnson & Johnson, Merck, Roche, China Resources Double Crane Pharmaceuticals, Hengrui Medicine, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dental Anti-inflammatory Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dental Anti-inflammatory Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dental Anti-inflammatory Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dental Anti-inflammatory Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Dental Anti-inflammatory Drugs Segment by Company

3M

Yunnan Baiyao Group

Johnson & Johnson

Merck

Roche

China Resources Double Crane Pharmaceuticals

Hengrui Medicine

GSK

Bayer

Sunstar

Septodont

DenMat

Colgate-Palmolive

Bausch Health

Acteon

Dental Anti-inflammatory Drugs Segment by Type

Non-steroidal Anti-inflammatory Drugs

Antibiotics

Steroidal Anti-inflammatory Drugs

Others

Dental Anti-inflammatory Drugs Segment by Application

Clinics

Hospitals

Pharmacies

Online Sales

Others

Dental Anti-inflammatory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dental Anti-inflammatory Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dental Anti-inflammatory Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dental Anti-inflammatory Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Dental Anti-inflammatory Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Anti-inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dental Anti-inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Anti-inflammatory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dental Anti-inflammatory Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dental Anti-inflammatory Drugs industry.

Chapter 3: Detailed analysis of Dental Anti-inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dental Anti-inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dental Anti-inflammatory Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dental Anti-inflammatory Drugs Industry Trends Table 2. Dental Anti-inflammatory Drugs Industry Drivers Table 3. Dental Anti-inflammatory Drugs Industry Opportunities and Challenges Table 4. Dental Anti-inflammatory Drugs Industry Restraints Table 5. Global Dental Anti-inflammatory Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dental Anti-inflammatory Drugs Revenue Share by Company (2021-2026) Table 7. Global Dental Anti-inflammatory Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dental Anti-inflammatory Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Dental Anti-inflammatory Drugs Average Price (USD/unit) of Company (2021-2026) Table 10. Global Dental Anti-inflammatory Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dental Anti-inflammatory Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Dental Anti-inflammatory Drugs Company, Product Type & Application Table 13. Global Dental Anti-inflammatory Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dental Anti-inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Non-steroidal Anti-inflammatory Drugs Table 18. Significant Companies of Antibiotics Table 19. Significant Companies of Steroidal Anti-inflammatory Drugs Table 20. Significant Companies of Others Table 21. Global Dental Anti-inflammatory Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Dental Anti-inflammatory Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Dental Anti-inflammatory Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Dental Anti-inflammatory Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Dental Anti-inflammatory Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Dental Anti-inflammatory Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dental Anti-inflammatory Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Dental Anti-inflammatory Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Dental Anti-inflammatory Drugs Sales Value Share by Type (2021-2026) Table 30. Global Dental Anti-inflammatory Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinics Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Pharmacies Table 34. Significant Companies of Online Sales Table 35. Significant Companies of Others Table 36. Global Dental Anti-inflammatory Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Dental Anti-inflammatory Drugs Sales Volume by Application (2021-2026) & (k units) Table 38. Global Dental Anti-inflammatory Drugs Sales Volume by Application (2027-2032) & (k units) Table 39. Global Dental Anti-inflammatory Drugs Sales Volume Share by Application (2021-2026) Table 40. Global Dental Anti-inflammatory Drugs Sales Volume Share by Application (2027-2032) Table 41. Global Dental Anti-inflammatory Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Dental Anti-inflammatory Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Dental Anti-inflammatory Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Dental Anti-inflammatory Drugs Sales Value Share by Application (2021-2026) Table 45. Global Dental Anti-inflammatory Drugs Sales Value Share by Application (2027-2032) Table 46. Global Dental Anti-inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Dental Anti-inflammatory Drugs Sales by Region (2021-2026) & (k units) Table 48. Global Dental Anti-inflammatory Drugs Sales Market Share by Region (2021-2026) Table 49. Global Dental Anti-inflammatory Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Dental Anti-inflammatory Drugs Sales Market Share by Region (2027-2032) Table 51. Global Dental Anti-inflammatory Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Dental Anti-inflammatory Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Dental Anti-inflammatory Drugs Sales Value Share by Region (2021-2026) Table 54. Global Dental Anti-inflammatory Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Dental Anti-inflammatory Drugs Sales Value Share by Region (2027-2032) Table 56. Global Dental Anti-inflammatory Drugs Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Dental Anti-inflammatory Drugs Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Dental Anti-inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Dental Anti-inflammatory Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (k units) Table 61. Global Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2026) Table 62. Global Dental Anti-inflammatory Drugs Sales by Country (2027-2032) & (k units) Table 63. Global Dental Anti-inflammatory Drugs Sales Market Share by Country (2027-2032) Table 64. Global Dental Anti-inflammatory Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Dental Anti-inflammatory Drugs Sales Value Market Share by Country (2021-2026) Table 66. Global Dental Anti-inflammatory Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Dental Anti-inflammatory Drugs Sales Value Market Share by Country (2027-2032) Table 68. 3M Company Information Table 69. 3M Business Overview Table 70. 3M Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. 3M Dental Anti-inflammatory Drugs Product Portfolio Table 72. 3M Recent Development Table 73. Yunnan Baiyao Group Company Information Table 74. Yunnan Baiyao Group Business Overview Table 75. Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio Table 77. Yunnan Baiyao Group Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Merck Dental Anti-inflammatory Drugs Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Roche Dental Anti-inflammatory Drugs Product Portfolio Table 92. Roche Recent Development Table 93. China Resources Double Crane Pharmaceuticals Company Information Table 94. China Resources Double Crane Pharmaceuticals Business Overview Table 95. China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio Table 97. China Resources Double Crane Pharmaceuticals Recent Development Table 98. Hengrui Medicine Company Information Table 99. Hengrui Medicine Business Overview Table 100. Hengrui Medicine Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio Table 102. Hengrui Medicine Recent Development Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. GSK Dental Anti-inflammatory Drugs Product Portfolio Table 107. GSK Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Bayer Dental Anti-inflammatory Drugs Product Portfolio Table 112. Bayer Recent Development Table 113. Sunstar Company Information Table 114. Sunstar Business Overview Table 115. Sunstar Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Sunstar Dental Anti-inflammatory Drugs Product Portfolio Table 117. Sunstar Recent Development Table 118. Septodont Company Information Table 119. Septodont Business Overview Table 120. Septodont Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Septodont Dental Anti-inflammatory Drugs Product Portfolio Table 122. Septodont Recent Development Table 123. DenMat Company Information Table 124. DenMat Business Overview Table 125. DenMat Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. DenMat Dental Anti-inflammatory Drugs Product Portfolio Table 127. DenMat Recent Development Table 128. Colgate-Palmolive Company Information Table 129. Colgate-Palmolive Business Overview Table 130. Colgate-Palmolive Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio Table 132. Colgate-Palmolive Recent Development Table 133. Bausch Health Company Information Table 134. Bausch Health Business Overview Table 135. Bausch Health Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Bausch Health Dental Anti-inflammatory Drugs Product Portfolio Table 137. Bausch Health Recent Development Table 138. Acteon Company Information Table 139. Acteon Business Overview Table 140. Acteon Dental Anti-inflammatory Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Acteon Dental Anti-inflammatory Drugs Product Portfolio Table 142. Acteon Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Dental Anti-inflammatory Drugs Distributors List Table 146. Dental Anti-inflammatory Drugs Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Dental Anti-inflammatory Drugs Product Image Figure 2. Global Dental Anti-inflammatory Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dental Anti-inflammatory Drugs Sales (2021-2032) & (k units) Figure 5. Global Dental Anti-inflammatory Drugs Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Dental Anti-inflammatory Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Non-steroidal Anti-inflammatory Drugs Image Figure 10. Antibiotics Image Figure 11. Steroidal Anti-inflammatory Drugs Image Figure 12. Others Image Figure 13. Global Dental Anti-inflammatory Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Dental Anti-inflammatory Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Dental Anti-inflammatory Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Dental Anti-inflammatory Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dental Anti-inflammatory Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Dental Anti-inflammatory Drugs Sales Value Share by Type (2021-2032) Figure 19. Clinics Image Figure 20. Hospitals Image Figure 21. Pharmacies Image Figure 22. Online Sales Image Figure 23. Others Image Figure 24. Global Dental Anti-inflammatory Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Dental Anti-inflammatory Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Dental Anti-inflammatory Drugs Sales Volume Share by Application (2021-2032) Figure 27. Global Dental Anti-inflammatory Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dental Anti-inflammatory Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Dental Anti-inflammatory Drugs Sales Value Share by Application (2021-2032) Figure 30. Global Dental Anti-inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Dental Anti-inflammatory Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Dental Anti-inflammatory Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Dental Anti-inflammatory Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. North America Dental Anti-inflammatory Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Dental Anti-inflammatory Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Dental Anti-inflammatory Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. South America Dental Anti-inflammatory Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Dental Anti-inflammatory Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Dental Anti-inflammatory Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Dental Anti-inflammatory Drugs Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Dental Anti-inflammatory Drugs Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Non-steroidal Anti-inflammatory Drugs
  • Antibiotics
  • Steroidal Anti-inflammatory Drugs
  • Others
Applications
  • Clinics
  • Hospitals
  • Pharmacies
  • Online Sales
  • Others
Companies covered
  • 3M
  • Yunnan Baiyao Group
  • Johnson & Johnson
  • Merck
  • Roche
  • China Resources Double Crane Pharmaceuticals
  • Hengrui Medicine
  • GSK
  • Bayer
  • Sunstar
  • Septodont
  • DenMat
  • Colgate-Palmolive
  • Bausch Health
  • Acteon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Dental Anti-inflammatory Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Dental Anti-inflammatory Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dental Anti-inflammatory Drugs Market Dynamics
  1. 2.1 Dental Anti-inflammatory Drugs Industry Trends
  2. 2.2 Dental Anti-inflammatory Drugs Industry Drivers
  3. 2.3 Dental Anti-inflammatory Drugs Industry Opportunities and Challenges
  4. 2.4 Dental Anti-inflammatory Drugs Industry Restraints
3 Dental Anti-inflammatory Drugs Market by Company
  1. 3.1 Global Dental Anti-inflammatory Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Dental Anti-inflammatory Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Dental Anti-inflammatory Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Dental Anti-inflammatory Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Dental Anti-inflammatory Drugs Company Ranking (2024-2026)
  6. 3.6 Global Dental Anti-inflammatory Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Dental Anti-inflammatory Drugs Company Product Type and Application
  8. 3.8 Global Dental Anti-inflammatory Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dental Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dental Anti-inflammatory Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dental Anti-inflammatory Drugs Market by Type
  1. 4.1 Dental Anti-inflammatory Drugs Type Introduction
  2. 4.1.1 Non-steroidal Anti-inflammatory Drugs
  3. 4.1.2 Antibiotics
  4. 4.1.3 Steroidal Anti-inflammatory Drugs
  5. 4.1.4 Others
  6. 4.2 Global Dental Anti-inflammatory Drugs Sales Volume by Type
  7. 4.2.1 Global Dental Anti-inflammatory Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dental Anti-inflammatory Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Dental Anti-inflammatory Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Dental Anti-inflammatory Drugs Sales Value by Type
  11. 4.3.1 Global Dental Anti-inflammatory Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dental Anti-inflammatory Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Dental Anti-inflammatory Drugs Sales Value Share by Type (2021-2032)
5 Dental Anti-inflammatory Drugs Market by Application
  1. 5.1 Dental Anti-inflammatory Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Pharmacies
  5. 5.1.4 Online Sales
  6. 5.1.5 Others
  7. 5.2 Global Dental Anti-inflammatory Drugs Sales Volume by Application
  8. 5.2.1 Global Dental Anti-inflammatory Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Dental Anti-inflammatory Drugs Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Dental Anti-inflammatory Drugs Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Dental Anti-inflammatory Drugs Sales Value by Application
  12. 5.3.1 Global Dental Anti-inflammatory Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Dental Anti-inflammatory Drugs Sales Value by Application (2021-2032)
  14. 5.3.3 Global Dental Anti-inflammatory Drugs Sales Value Share by Application (2021-2032)
6 Dental Anti-inflammatory Drugs Regional Sales and Value Analysis
  1. 6.1 Global Dental Anti-inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dental Anti-inflammatory Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Dental Anti-inflammatory Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Dental Anti-inflammatory Drugs Sales by Region (2027-2032)
  5. 6.3 Global Dental Anti-inflammatory Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dental Anti-inflammatory Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dental Anti-inflammatory Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dental Anti-inflammatory Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Dental Anti-inflammatory Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Dental Anti-inflammatory Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Dental Anti-inflammatory Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dental Anti-inflammatory Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Dental Anti-inflammatory Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dental Anti-inflammatory Drugs Sales Value Share by Country, 2025 VS 2032
7 Dental Anti-inflammatory Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Dental Anti-inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dental Anti-inflammatory Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Dental Anti-inflammatory Drugs Sales by Country (2027-2032)
  6. 7.4 Global Dental Anti-inflammatory Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dental Anti-inflammatory Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dental Anti-inflammatory Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dental Anti-inflammatory Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dental Anti-inflammatory Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dental Anti-inflammatory Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 3M
  2. 8.1.1 3M Company Information
  3. 8.1.2 3M Business Overview
  4. 8.1.3 3M Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 3M Dental Anti-inflammatory Drugs Product Portfolio
  6. 8.1.5 3M Recent Developments
  7. 8.2 Yunnan Baiyao Group
  8. 8.2.1 Yunnan Baiyao Group Company Information
  9. 8.2.2 Yunnan Baiyao Group Business Overview
  10. 8.2.3 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio
  12. 8.2.5 Yunnan Baiyao Group Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Dental Anti-inflammatory Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Roche Dental Anti-inflammatory Drugs Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 China Resources Double Crane Pharmaceuticals
  32. 8.6.1 China Resources Double Crane Pharmaceuticals Company Information
  33. 8.6.2 China Resources Double Crane Pharmaceuticals Business Overview
  34. 8.6.3 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio
  36. 8.6.5 China Resources Double Crane Pharmaceuticals Recent Developments
  37. 8.7 Hengrui Medicine
  38. 8.7.1 Hengrui Medicine Company Information
  39. 8.7.2 Hengrui Medicine Business Overview
  40. 8.7.3 Hengrui Medicine Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio
  42. 8.7.5 Hengrui Medicine Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GSK Dental Anti-inflammatory Drugs Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Dental Anti-inflammatory Drugs Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Sunstar
  56. 8.10.1 Sunstar Company Information
  57. 8.10.2 Sunstar Business Overview
  58. 8.10.3 Sunstar Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sunstar Dental Anti-inflammatory Drugs Product Portfolio
  60. 8.10.5 Sunstar Recent Developments
  61. 8.11 Septodont
  62. 8.11.1 Septodont Company Information
  63. 8.11.2 Septodont Business Overview
  64. 8.11.3 Septodont Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Septodont Dental Anti-inflammatory Drugs Product Portfolio
  66. 8.11.5 Septodont Recent Developments
  67. 8.12 DenMat
  68. 8.12.1 DenMat Company Information
  69. 8.12.2 DenMat Business Overview
  70. 8.12.3 DenMat Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 DenMat Dental Anti-inflammatory Drugs Product Portfolio
  72. 8.12.5 DenMat Recent Developments
  73. 8.13 Colgate-Palmolive
  74. 8.13.1 Colgate-Palmolive Company Information
  75. 8.13.2 Colgate-Palmolive Business Overview
  76. 8.13.3 Colgate-Palmolive Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio
  78. 8.13.5 Colgate-Palmolive Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Dental Anti-inflammatory Drugs Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 Acteon
  86. 8.15.1 Acteon Company Information
  87. 8.15.2 Acteon Business Overview
  88. 8.15.3 Acteon Dental Anti-inflammatory Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Acteon Dental Anti-inflammatory Drugs Product Portfolio
  90. 8.15.5 Acteon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dental Anti-inflammatory Drugs Value Chain Analysis
  2. 9.1.1 Dental Anti-inflammatory Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dental Anti-inflammatory Drugs Sales Mode & Process
  6. 9.2 Dental Anti-inflammatory Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dental Anti-inflammatory Drugs Distributors
  9. 9.2.3 Dental Anti-inflammatory Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst